Equity Research - Brady’s Initiation Report

<p>Brady plc (“Brady” or “the company”) is a UK-headquartered technology company, listed on AIM (LSE) since 2004. The company operates in the energy and commodity trading and risk management (ECTRM) market<br />
and provides software solutions and services to more than 250 customers worldwide, including producers, fabricators, brokers, traders, banks, and hedge funds.</p>

<p>Brady’s revenues have increased dramatically since 2007, when the company initiated a new growth strategy based on aggressive expansion through acquisitions. Brady has successfully assimilated its three most recent purchases (Viz, Navita and syseca), gaining a significant share in the European ETRM1 sector and becoming the largest publicly-held vendor engaged in the ETRM market2. Consequently, it is of no surprise that Brady’s stock&nbsp;price has performed very well in the last twelve months, increasing by more than 29%3, as investors appear to appreciate the company’s strategic direction. Given management’s solid track record and a strong cash position&nbsp;(with zero debt), we expect Brady to further extend its presence in the market by seeking new investment opportunities in the ECTRM sector, which in turn is driven by increasing regulatory requirements and technological advancements. Although the majority of Brady’s revenues are currently generated in one region (EMEA), the company plans to pursue opportunities in emerging markets, such as the APAC region, which is a less saturated market.</p>

<p>Our valuation, based on a combination of intrinsic DCF-based method and relative valuation techniques, and built on a set of relatively conservative assumptions, suggests that Brady’s shares are currently fairly priced. We&nbsp;therefore rate the company as Hold.</p>

  • LinkedIn  
  • Save this article
  • Print this page  

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@chartis-research.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Chartis Research? View our subscription options

You need to sign in to use this feature. If you don’t have a Chartis account, please register for an account.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here.